Steven M. Paul

25.7k citations

117 papers · 16.4k indexed · 5 hit papers · h-index 66

Neurology top 0.05%
- Neuroinflammation and Neurodegeneration Mechanisms 20
Physiology top 0.05%
- Alzheimer's disease research and treatments 79
Biological Psychiatry top 0.2%
Cellular and Molecular Neuroscience top 0.2%
- Neuroscience and Neuropharmacology Research 15
- Nuclear Receptors and Signaling 13
Pharmacology top 0.1%
- Cholinesterase and Neurodegenerative Diseases 21
Computational Theory and Mathematics
- Computational Drug Discovery Methods 12
Psychiatry and Mental health
- Dementia and Cognitive Impairment Research 10
Molecular Biology
- S100 Proteins and Annexins 9

Co-authors: Kelly R. Bales David M. Holtzman Ronald B. DeMattos Maia Parsadanian Jean‐Cosme Dodart David J. Cummins Anne M. Fagan Chantal Mathis
Cited by: Neurology Physiology Biological Psychiatry
Journals: Science (2 papers)Proceedings of the National Academy of Sciences (7 papers)Journal of Biological Chemistry (5 papers)
Partner nations: United States Canada France

In The Last Decade

Steven M. Paul

116 papers receiving 16.1k citations

Hit Papers

5 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2011 Science Translational Medicine
2005 Proceedings of the National Academy of Sciences
2002 Nature Neuroscience
2001 Proceedings of the National Academy of Sciences
2000 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Steven M. Paul

Since Specialization

Citations

This map shows the geographic impact of Steven M. Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Paul more than expected).

Fields of papers citing papers by Steven M. Paul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Paul. The network helps show where Steven M. Paul may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven M. Paul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven M. Paul Line = papers co-authored together Steven M. Paul links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Chocolate Brown HT Inhibits the Contractile Activity of the Small Intestinal Visceral Smooth Muscle in Male Albino Rats International Journal of Science and Healthcare Research ·Soumi Biswas,Steven M. Paul,Sourapriya Mukherjee,Kamalesh Das,Goutam Paul	2025	0
2	Targeting apolipoprotein E for treating Alzheimer’s disease Neuroscience Letters ·Kelly R. Bales,Steven M. Paul	2019	5
3	AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease PubMed ·Jonathan B. Rosenberg,Michael G. Kaplitt,Bishnu P. De,Alvin Chen,Thomas Flagiello,Christiana O. Salami,Eduard Pey,Lingzhi Zhao,Rodolfo J Ricart Arbona,Sébastien Monette,Jonathan P. Dyke,Douglas Ballon,Stephen M. Kaminsky,Dolan Sondhi,Gregory A. Petsko,Steven M. Paul,Ronald G. Crystal	2018	123
4	Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function Nature Communications ·Kenzo Koizumi,Yorito Hattori,Sung Ji Ahn,Izaskun Buendía,Antonio Ciacciarelli,Ken Uekawa,Gang Wang,Abigail J. Hiller,Lingzhi Zhao,Henning U. Voss,Steven M. Paul,Chris B. Schaffer,Laibaik Park,Costantino Iadecola	2018	114
5	Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models Neurobiology of Aging ·Lingzhi Zhao,Andrew J. Gottesdiener,Mayur Parmar,Mingjie Li,Stephen M. Kaminsky,Marı́a J. Chiuchiolo,Dolan Sondhi,Patrick M. Sullivan,David M. Holtzman,Ronald G. Crystal,Steven M. Paul	2016	71
6	TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy Neuron ·Peng Yuan,Carlo Condello,C. Dirk Keene,Yaming Wang,Thomas D. Bird,Steven M. Paul,Wenjie Luo,Marco Colonna,David Baddeley,Jaime Grutzendler	2016	135
7	Hypertension enhances A β -induced neurovascular dysfunction, promotes β -secretase activity, and leads to amyloidogenic processing of APP Journal of Cerebral Blood Flow & Metabolism ·Giuseppe Faraco,Laibaik Park,Ping Zhou,Wenjie Luo,Steven M. Paul,Josef Anrather,Costantino Iadecola	2015	133
8	Transcriptomic Analysis of Induced Pluripotent Stem Cells Derived from Patients with Bipolar Disorder from an Old Order Amish Pedigree PLoS ONE ·Kwi Hye Kim,Jiangang Liu,Rachelle J. Sells Galvin,Jeffrey L. Dage,Janice A. Egeland,Rosamund C. Smith,Kalpana Merchant,Steven M. Paul	2015	26
9	Macrophage-Mediated Degradation of β-Amyloid via an Apolipoprotein E Isoform-Dependent Mechanism Journal of Neuroscience ·Lingzhi Zhao,Suizhen Lin,Kelly R. Bales,Valentina Gelfanova,Deanna Koger,Cynthia DeLong,John E. Hale,Feng Liu,Jesse M. Hunter,Steven M. Paul	2009	60
10	Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease Journal of Clinical Investigation ·Suzanne E. Wahrle,Hong Jiang,Maia Parsadanian,Jungsu Kim,Aimin Li,Amanda Knoten,Sanjay Jain,Veronica Hirsch‐Reinshagen,Cheryl L. Wellington,Kelly R. Bales,Steven M. Paul,David M. Holtzman	2008	311
11	Liver X Receptor-Mediated Gene Regulation and Cholesterol Homeostasis in Brain: Relevance to Alzheimers Disease Therapeutics Current Alzheimer Research ·Guoqing Cao,Kelly R. Bales,Ronald B. DeMattos,Steven M. Paul	2007	63
12	Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms Neurobiology of Aging ·David A. Costa,Jennifer R. Cracchiolo,Adam D. Bachstetter,Tiffany F. Hughes,Kelly R. Bales,Steven M. Paul,Ronald F. Mervis,Gary W. Arendash,Huntington Potter	2006	181
13	Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice Journal of Clinical Investigation ·Robert P. Brendza,Brian J. Bacskai,John R. Cirrito,Kelly Simmons,Jesse Skoch,William E. Klunk,Chester A. Mathis,Kelly R. Bales,Steven M. Paul,Bradley T. Hyman,David M. Holtzman	2005	23
14	ApoAI Deficiency Results in Marked Reductions in Plasma Cholesterol But No Alterations in Amyloid-β Pathology in a Mouse Model of Alzheimer's Disease-Like Cerebral Amyloidosis American Journal Of Pathology ·Anne M. Fagan,Erin Christopher,Jennie Taylor,Maia Parsadanian,Michael Spinner,Melanie Watson,John Denis Fryer,Suzanne E. Wahrle,Kelly R. Bales,Steven M. Paul,David M. Holtzman	2004	46
15	Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer’s transgenic mouse lines differing in Aβ deposition Behavioural Brain Research ·Ralph E. Leighty,Lars Nilsson,Huntington Potter,David A. Costa,Mark A Low,Kelly R. Bales,Steven M. Paul,Gary W. Arendash	2004	40
16	Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease PMC ·Richard E. Hartman,Helmut Laurer,Luca Longhi,Kelly R. Bales,Steven M. Paul,Tracy K. McIntosh,David M. Holtzman	2002	1
17	Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injury Annals of Neurology ·Kara L. Arvin,Byung Hee Han,Yansheng Du,Sui‐Zhen Lin,Steven M. Paul,David M. Holtzman	2002	262
18	Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APP V717F transgenic mice Acta Neuropathologica ·Michael C. Irizarry,Bonnie Cheung,G. William Rebeck,Steven M. Paul,Kelly R. Bales,Bradley T. Hyman	2000	77
19	Overexpression of the Neuritotrophic Cytokine S100β Precedes the Appearance of Neuritic β‐Amyloid Plaques in APPV717F Mice Journal of Neurochemistry ·Jin G. Sheng,Robert E. Mrak,Kelly R. Bales,Barbara Cordell,Steven M. Paul,Richard A. Jones,S Woodward,Xue Zhou,John M. McGinness,W. Sue T. Griffin	2000	67
20	Cloning and expression of a rat brain interleukin-1beta-converting enzyme (ICE)-related protease (IRP) and its possible role in apoptosis of cultured cerebellar granule neurons PMC ·Binhui Ni,Xin Wu,Yansheng Du,Yuan Su,Elizabeth Hamilton‐Byrd,Pamela K. Rockey,Paul R. Rosteck,Guy G. Poirier,Steven M. Paul	1997	9

About Steven M. Paul

Steven M. Paul is a scholar working on Physiology, Neurology and Cellular and Molecular Neuroscience, having authored 117 papers that have together received 16.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (79 papers), Cholinesterase and Neurodegenerative Diseases (21 papers), Neuroinflammation and Neurodegeneration Mechanisms (20 papers), Neuroscience and Neuropharmacology Research (15 papers), Nuclear Receptors and Signaling (13 papers), Computational Drug Discovery Methods (12 papers), Dementia and Cognitive Impairment Research (10 papers) and S100 Proteins and Annexins (9 papers). The work is most often cited by research in Neurology (3.8k citations), Physiology (11.6k citations) and Biological Psychiatry (978 citations). Steven M. Paul has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Kelly R. Bales, David M. Holtzman, Ronald B. DeMattos, Maia Parsadanian, Jean‐Cosme Dodart, David J. Cummins, Anne M. Fagan, Chantal Mathis, Xin Wu and Mark Odell. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact